Immediate Impact

2 by Nobel laureates 2 from Science/Nature 51 standout
Sub-graph 1 of 25

Citing Papers

The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis
2024 Standout
Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer
2017 Standout
2 intermediate papers

Works of R E Partridge being referenced

TOPICAL: Randomized phase III trial of erlotinib compared with placebo in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and unsuitable for first-line chemotherapy.
2010
Controlled Trial of the Effect of Complete Immobilization of the Joints in Rheumatoid Arthritis
1963

Author Peers

Author Last Decade Papers Cites
R E Partridge 148 42 24 91 83 16 426
Inyong Hwang 211 25 6 77 85 17 403
Anette Jørgensen 197 35 5 78 43 16 372
K. L. Schmidt 147 38 14 59 16 21 398
Qing Yu Zeng 298 85 5 84 72 14 481
Michele Hooper 198 94 12 43 58 16 494
Elaine Smith 245 83 7 98 56 14 496
Ásmundur Brekkan 214 35 4 154 41 18 389
Elizabeth Stone 56 34 93 33 15 376
J. M. Le Parc 190 83 4 79 57 21 384
Enijad Sahinbegovic 264 131 5 89 99 13 504

All Works

Loading papers...

Rankless by CCL
2026